specialty drugs reference catalog - mckesson
TRANSCRIPT
1
Specialty Drugs Reference CatalogSummer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
2Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
Distribution you can count on
• Over 17,000 pharmaceuticals in stock nationwide
• Drug Supply Chain Security Act (DSCSA)-compliant
• Reliable multi-channel communications platform
• Real-time access to purchasing data and product documents
• Safe storage and fast professional delivery
Contents
Featured Product >
ZILRETTA® is the first and only FDA-approved extended-release intra-articular therapy for osteoarthritis-related knee pain utilizing microsphere technology.
Get to know ZILRETTA®
Pharmaceutical Programs >
Serving Outpatient Care >
New Products >
Hyaluronic Acid (HA) Injections >
Women’s Health >
Featured Product >
Manufacturer Billing Resources >
Professional Resources >
Product Listing >
3Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional Resources Product Listing
Contents
Pharmaceutical programsChildhood and adult vaccines
• We have the vaccines you need for adults and pediatrics
• One order to place for all supplies on one invoice
• Save on shipping and receive next day delivery on orders
• Confidently order what you need and return expired vaccines, if necessary.
• All necessary DSCSA regulatory data maintained easily on McKesson SupplyManagerSM
Influenza vaccines Let McKesson FluWise® help you get ready for flu, with our comprehensive, year-round program giving you access to a variety of flu products, savings and support every step of the way.
When you order flu vaccines from us, you get:
• No limit on shipping locations per order
• Dedicated flu team
• Extended terms
• Seasonal supplies
• Year-round promotional offers
Contact your McKesson Account Manager or visit mms.mckesson.com or call 866.625.2679
Pharmaceutical Programs
Specialty drugsDon’t have time to keep up with the changes and all the new products?
We do. Our priority is making sure your practice is up to date and benefits from safe medical distribution, ordering efficiency, reliable communications, and stable pricing programs. All these options will help you create a more personalized patient experience.
6 in 10 adults in the US have chronic disease1
We distribute more pharmaceutical products to alternate care settings than any other distributor and with every order, you can count on choice, reliable distribution, smart solutions and a team of experts at your side.
Explore our growing specialty drugs portfolio and helpful resources with this interactive catalog.
GenericsNo matter your care setting we have the generics you need, including:
• Corticosteroids
• Analgesics
• Anti-infectives
• Anesthetics
• Cardiovascular agents
• Ophthalmic agents
• Hormone agents and suppressants
• And more!
Pharmaceutical services• CSOS – Electronic CII Ordering
• McKesson Business Analytics
• Pharmaceutical Disposal
• SDS Reporting
4Specialty Drugs Catalog | Summer 2020
HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
Serving Outpatient Care
Committed to outpatient care
Orthopedics1% Sodium HyaluronateDUROLANE®
EUFLEXXA®
GenVisc® 850Gel-One®
GELSYN-3®
HYALGAN®
HYMOVIS®
Orthovisc®
Monovisc®
SUPARTZ-FX®
Synvisc®
Synvisc One®
TRILURON™
TriVisc®
Visco-3™
ZILRETTA®
Family Practice/ Internal Medicine/ Multi SpecialtyBotox®
EVENITY®
Otiprio®
Prolia®
Daptomycin®
Ertapenem®
ZINPLAVA®
CardiologyLexiscan®
NeurologyBOTOX® (Therapeutic)Lioresal®
UrologyBOTOX®
Firmagon®
ELIGARD®
OB/GYNSkyla®
Kyleena®
Mirena®
LILETTA®
Prolia®
EVENITY®
Surgery CenterAnjeso®
Dextenza®
EXPAREL®
DEXYCU®
Otiprio®
Distribution designed to address the unique needs of independent practices, large groups and complex health systems.
We continue to add products and support for over 100 primary care and specialized outpatient care settings. See complete list of products here.
A fleet delivering 5 days a week
Next-day deliveryto 95% of the United States95%
Over 17,000 pharmaceuticalsin stock nationwide
99.8% order accuracy
5Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s Health Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
New Products
New productsTRILURON™ McKesson Item Number: 1153617
Manufacturer Fidia Pharma has introduced TRILURON™ (sodium hyaluronate), a three-injection hyaluronic acid (HA) based intra-articular viscosupplements treatment.
The chemical formulation of TRILURON™ is identical to Hyalgan®, Fidia’s five-injection regimen.
TRILURON™ is used in orthopedic pain management.
• HCPCS Code: J7332
DEXYCU®
McKesson Item Number: 1160736
DEXYCU® (dexamethasone intraocular suspension 9%) is the FDA-approved, single-dose, sustained release, intracameral steroid for the treatment of cataract post-operative inflammation.
DEXYCU® is injected into the eye at the end of eye surgery and its effects may last up to 30 days.
DEXYCU® is used in surgery centers.
• HCPCS Code: J1095
See updated Package Insert for full prescribing information including warnings, precautions and side effects.
See updated Package Insert for full prescribing information including warnings, precautions and side effects.
6Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
HA Injections
Hyaluronic acid (HA) injectionsDeciding on the right sodium hyaluronate (HA) injection for your patients can be difficult. Especially when you are weighing clinical benefits, patient profiles and product reimbursement. Our broad portfolio of HA injections can help support the diverse needs of your practice.
Manufacturer updates• Fidia launches TRILURON®, a 3-injection therapy to join 2-injection
Hymovis® and 5-injection Hyalgan®. View revised Package Insert.
• McKesson is now administering GPO contracts on Synvisc® and Synvisc-One®.
Sodium Hyaluronate (HA) Injections
Product Item Number ManufacturerInjections
Per TherapyReimbursement
CodePackage
Insert
DUROLANE® 1088743 Bioventus 1x J7318
Gel-One® 896819 Zimmer 1x J7326
Synvisc-One® 696400 Sanofi 1x J7328
HYMOVIS® 1056253 Fidia 2x J7322
GELSYN-3™ 1037328 Bioventus 3x J7328
1% Sodium Hyaluronate 1140016 Teva 3x J7331
EUFLEXXA® 1032307 Ferring 3x J7323
Synvisc® 340307 Sanofi 3x J7328
Visco-3™ 1094393 Zimmer 3x J7333
TriVisc® 1124261 OrthogenRx 3x J7329
TRILURON™ 1153617 Fidia 3x J7332
HYALGAN® 1032048/1032049 Fidia 5x J7321
GenVisc® 850 1073894 OrthogenRx 5x J7320
SUPARTZ-FX® 532271 Bioventus 5x J7321
NEW
Distributing viscosupplementation (hyaluronic acid) injectable treatments to:
• Orthopedics
• Pain management clinics
• Physical therapy
• Multi-specialty groups
• Rheumatology
• Family practice
• Health systems
• And more
7Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA InjectionsNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
Women’s Health
Women’s healthThere is a good chance your patients learn about new therapies before you. We can help you stay in-the-know on manufacturer updates and new products that can help you create a personalized patient experience.
Manufacturer updates• LILETTA® receives FDA approval for extended use for up to 6 years.
Read the Press Release.
• Bayer IUD’s are levonorgestrel-releasing intrauterine systems. Mirena® prevents heavy menstrual bleeding and pregnancy for up to 5 years. Kyleena® prevents pregnancy for up to 5 years. Skyla prevents pregnancy for up to 3 years. Bayer has a submission with the FDA to extend the duration of use for Mirena for up to 6 years – we continue to watch for changes.
Bone Health
Product Item Number ManufacturerReimbursement
CodePackage
Insert
Prolia® 729015 Amgen J0897
EVENITY™ 1133836 Amgen J3111
Intrauterine Devices (IUDs)
Product Item Number ManufacturerReimbursement
CodePackage
Insert
Mirena® 1126374 Bayer J7298
Kyleena® 1126376 Bayer J7296
Skyla® 1126375 Bayer J7301
LILETTA® 1058636 Allergan J2797
Distributing women’s health medications and therapies to:
• OB/GYN
• Multi-specialty clinics
• Community health clinics
• Internal medicine
• Family practice
• Endocrinology
• Orthopedics
• And more
Black Box Warning
8Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
Featured Product
Featured productZILRETTA®
McKesson Item Number: 1134726
ZILRETTA® is the FDA-approved extended-release intra-articular therapy for osteoarthritis-related knee pain utilizing microsphere technology.
In December 2019 the Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) that includes and updated Limitation of Use statement for repeat administration among other changes.
• HCPCS Code: J3304
See updated Package Insert for full prescribing information including warnings, precautions and side effects.
Osteoarthritis
Risk factors• Age (those 50+
are most at risk)• Joint injury• Overuse• Obesity
Patient Impact• Pain• Depression• Activity limitations• Work limitations
OA increases the risk of developing heart disease by 50%2
• Weak muscles• Genetic disposition• Gender (women
are most likely to develop OA)
9Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Professional ResourcesPharmaceutical Programs Product Listing
Contents
Billing Resources
Manufacturer billing resourcesBilling and coding information for your practice.
1% Sodium HyaluronateBilling Resource
Dextenza®
Billing Resource
DEXYCU®
Billing Resource
DUROLANE®
Billing Resource
EUFLEXXA®
Billing Resource
EXPAREL®
Billing Resource
GenVisc® 850Billing Resource
GELSYN-3™
Billing Resource
Gel One® and Visco-3®
Billing Resource
HYALGAN®
Billing Resource
HYMOVIS®
Billing Resource
Lexiscan®
Billing Resource
Lioresal®
Billing Resource
Otiprio®
Billing Resource
Looking for a billing resource not listed above? Let your McKesson Account Manager know and we’ll contact the manufacturer right away!
Prolia® and EVENITY®
Billing Resource
SUPARTZ-FX®
Billing Resource
Synvisc and Synvisc-OneBilling Resource
TRILURON™
Billing Resource
Trivisc®
Billing Resource
ZILRETTA®
Billing Resource
ZINPLAVA™
Billing Resource
10Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing ResourcesPharmaceutical Programs Product Listing
Contents
Professional Resources
Professional resourcesProtecting and improving Medicare for our nation’s seniors
Drug Supply Chain Security Act (DSCSA)DSCSA is administered by the Food and Drug Administration (FDA) and has these objectives:
• Pharmaceutical drug integrity
• Traceability of drugs through supply chain
• A system of unique product identifiers
• Robust transaction history and information
• Efficient verification requests, responses to suspect/illegitimate products, effective recalls as needed
• National licensure standards for wholesale distributors and third-party logistics organizations
Next Nov. 27, 2020, primary care providers and other dispensers may only accept products with valid Product Identifier.
Visit the FDA DSCSA Website for more information.
McKesson Medical-Surgical is DSCSA compliant.
Under Executive Order #13890, titled Protecting and Improving Medicare for Our Nation’s Seniors (specifically under Section 5), the Centers for Medicare and Medicaid Services (CMS), plans to propose reform to the Medicare program that would significantly impact Physician Assistants (PAs) and Advanced Practicing Registered Nurses (APRNs).
On January 17, 2020, the American College of Cardiology provided a written response to CMS outlining specific examples of cardiologic services that APPs should be able to provide under general physician supervision. Read the ASC Letter.
11Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs
Contents
Product Listing
All specialty pharmaceuticals
Product McKesson Item Numbers Manufacturer Reimbursement
Code
1% Sodium Hyaluronate 1140016 Teva J7331
BOTOX® (Therapeutic) 349702, 766957 Allergan J0585
Daptomycin 1129400 Sagent J0878
Daptomycin 1150791 NORTHSTAR J0878
Dextenza® 1137737, 1137736 Ocular Therapeutix J1096
DEXYCU® 1160736 EyePoint J1095
DUROLANE® 1088743 Bioventus J7318
Ertapenem 1112299, 1110229 Multiple J1335
EUFLEXXA® 1032307 Ferring J7323
EVENITY® 1133836 Amgen J3490/J3590
EXPAREL® 1055498, 806793, 1055711, 1055705 Pacira C9290
Firmagon® 870063, 916966 Ferring J9155
Gel-One® 896819 Zimmer J7326
Gelsyn-3™ 1037328 Bioventus J7328
GenVisc® 850 1073894 OrthogenRx J7320
HYALGAN® 1032048, 1032049 Fidia J7321
Product McKesson Item Numbers Manufacturer Reimbursement
Code
HYMOVIS® 1056253 Fidia J7322
Kyleena® 1126376 Bayer J7296
Lexiscan® 665602 Astellas J2785
LILETTA® 1058636 Allergan J7297
Lioresal®1113452, 1113453, 1113454, 1113455, 1113456, 1113457
Saol Contact MFG
Mirena® 1126374 Bayer J7298
Otiprio® 1083735 Otonomy J7342
Prolia® 729015 Amgen J0897
Skyla® 1126375 Bayer J7301
SUPARTZ-FX® 532271 Bioventus J7321
Synvisc® 340307 Sanofi J7325
Synvisc-One® 696400 Sanofi J7325
TRILURON™ 1153617 Fidia J7332
TriVisc™ 1124261 Orthogenix J7329
Visco-3™ 1094393 Zimmer J7321
ZILRETTA® 1134726 Flexion J3304
ZINPLAVA™ 1069979 Merck J0565
Our industry leading portfolio of pharmaceuticals.
12Specialty Drugs Catalog | Summer 2020
Serving Outpatient Care HA Injections Women’s HealthNew Products Featured Product Billing Resources Professional ResourcesPharmaceutical Programs Product Listing
Contents
McKesson is providing HCPCS/ CPT codes based upon information provided by the product manufacturers. McKesson does not make representations about the accuracy of this information. The HCPCS/ CPT codes do not indicate coverage or payment under any federal or state health care program. The entity that submits claims to any federal or state health care program has the responsibility to verify the accuracy of HCPCS/ CPT codes it submits for payment purposes.
The product information contained in this document, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers and have not been independently verified by McKesson Medical-Surgical or its affiliates (“McKesson”). McKesson is not responsible for errors or omissions in the product information. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Caution should be exercised when using or purchasing any products from McKesson’s online or print documents by closely examining the product packaging and the labeling prior to use. Due to product changes, information listed in this document is subject to change without notice. This information is placed solely for your convenience in ordering and McKesson disclaims all responsibility for its completeness and accuracy, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.
All trademarks and registered trademarks are the property of their respective owners. Actual savings may vary based upon products selected and other factors.
© 2020 McKesson Medical-Surgical Inc. 2020-0049
1https://cdc.gov/chronicdisease/about/index2https://oaaction.unc.edu/oa-module/oa-prevalence-and-burden/